Yttrium 90 radioembolization for the treatment of hepatocellular carcinoma: Biological lessons, current challenges, and clinical perspectives

Authors

  • Riad Salem,

    Corresponding author
    1. Department of Radiology, Section of Interventional Radiology and Division of Interventional Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
    • Address reprint requests to: Riad Salem, M.D., M.B.A., Division of Interventional Oncology, Department of Radiology, Northwestern University, 676 North St. Clair, Suite 800, Chicago, IL 60611. E-mail: r-salem@northwestern.edu; fax: 312-695-0654.

    Search for more papers by this author
    • All authors contributed equally to this review.

  • Vincenzo Mazzaferro,

    1. Gastrointestinal Surgery and Liver Transplantation Unit, National Cancer Institute, Istituto Nazionale Tumori IRCCS, Milan, Italy
    Search for more papers by this author
    • All authors contributed equally to this review.

  • Bruno Sangro

    1. Liver Unit, Clinica Universidad de Navarra, and Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas, Pamplona, Spain
    Search for more papers by this author
    • All authors contributed equally to this review.


  • R.S. is funded in part by the National Institutes of Health (grant no.: CA126809). V.M. is funded by the Italian Association for Cancer Research.

  • Potential conflict of interest: Dr. Sangro consults and is on the speakers' bureau for Sirtex Medical. Dr. Mazzaferro is on the speakers' bureau for and received grants from Bayer and Nordion. Dr. Salem consults, advises, and is on the speakers' bureau for Nordion. He consults for and advises Bayer and Sirtex Medical.

Ancillary